美国波士顿市马萨诸塞医院的依赛贝切医师(K.J.Isselbacher)及其合作者,提供了一种方法,能在一般症状出现之前,检查出很难发现的癌症,因而有助于及早治疗,增加治愈机会。这是癌症研究者们长期寻求的目标。这一方法是根据大多数癌症患者血液中含有半乳糖转移酶同功酶Ⅱ(GalactosyltransferaseⅡ,简称GT-Ⅱ)提出的, KJIsselbacher, MD, and his collaborators at the Massachusetts Hospital in Boston, United States, provided a method to detect hard-to-find cancers prior to the onset of general symptoms, thereby contributing to early treatment and increased healing. opportunity. This is the goal that cancer researchers have long sought. This method is based on the presence of galactosyltransferase II (GT-II) in the blood of most cancer patients.